North American Cannabis Stock Current Valuation
Valuation analysis of North American Cannabis helps investors to measure North American's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Undervalued
Today
Please note that North American's price fluctuation is out of control at this time. Calculation of the real value of North American Cannabis is based on 3 months time horizon. Increasing North American's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
North American's intrinsic value may or may not be the same as its current market price of 0.00, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0 | Real 0.0 | Hype 0.0 |
The intrinsic value of North American's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence North American's stock price.
Estimating the potential upside or downside of North American Cannabis helps investors to forecast how North pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of North American more accurately as focusing exclusively on North American's fundamentals will not take into account other important factors: North American Cannabis Company Current Valuation Analysis
North American's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current North American Current Valuation | 2.29 M |
Most of North American's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, North American Cannabis is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, North American Cannabis has a Current Valuation of 2.29 M. This is 99.98% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all United States stocks is 99.99% higher than that of the company.
North Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses North American's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of North American could also be used in its relative valuation, which is a method of valuing North American by comparing valuation metrics of similar companies.North American is currently under evaluation in current valuation category among its peers.
North Fundamentals
| Current Valuation | 2.29 M | |||
| Shares Outstanding | 22.88 B | |||
| Price To Sales | 224.21 X | |||
| Revenue | 742.34 K | |||
| Net Income | (334.06 K) | |||
| Total Debt | 1.62 M | |||
| Cash Flow From Operations | 284.44 K | |||
| Beta | -5.53 | |||
| Market Capitalization | 22.88 K | |||
| Total Asset | 775.6 K | |||
| Retained Earnings | (11.94 M) | |||
| Working Capital | (297 K) | |||
| Current Asset | 147 K | |||
| Current Liabilities | 444 K | |||
| Z Score | -21.0 | |||
| Net Asset | 775.6 K |
About North American Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze North American Cannabis's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of North American using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of North American Cannabis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in North Pink Sheet
North American financial ratios help investors to determine whether North Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in North with respect to the benefits of owning North American security.